12. Karow, M., and Georgopoulos, C. (1993 [2, 3] . ILC2s are local amplifiers of the type 2 immune response, releasing the key cytokine drivers of eosinophil infiltration (interleukin-5 (IL-5)) and of goblet and tuft cell hyperplasia (IL-13), as well as triggering fibrosis in response to signals such as alarmins secreted by epithelial cells [4] . Attention has focused on a troika of epithelial alarmins, namely: IL-33, a DNA-associated cytokine released upon cell damage; IL-25, produced by tuft cells in a taste-receptor signalingdependent manner; and thymic stromal lymphopoietin (TSLP), a predominant ILC2 activator in the skin [4, 5] . These mediators have been depicted in a simple bi-directional dialogue between stromal cells and immune cells that allows epithelial cells to flag and report an immune insult to ILC2s, which in turn instruct the epithelial barrier to condition itself against the immediate challenge, while kick-starting adaptive immunity to counteract chronic infections. A more profound network is now revealed by three recent reports [6] [7] [8] that introduce a multidirectional communication circuit between stromal, immune and nerve cells, in which ILC2s are a key intermediary in the crosstalk between the mucosa and the nervous system ( Figure 1A ). In this circuit, it is the release of the peptide neuromedin U (NMU) by cholinergic neurons [7, 8] that is the key event in ILC2 activation, demonstrating that type 2 immunity is not dictated exclusively by epithelial cells.
The neuropeptide NMU is a potent activator of two NMU receptors (NMURs), of which Nmur1 is specifically expressed by ILC2s in the lung and small intestine [6] [7] [8] , but only marginally [8] in other lymphoid and myeloid populations, suggesting that ILC2s are selectively responsive to the neuropeptide. ILC2-specific Nmur1 expression rises following either infection with the gastrointestinal helminth Nippostrongylus brasiliensis or intranasal allergen challenge [6] [7] [8] , concomitant with increased NMU expression in helminthinfected intestinal and lung tissue [7, 8] . In particular, increased Nmur1 expression correlates with the expression of the IL-33 receptor (ST2), but not the IL-25 receptor [6] , suggesting that Nmur1 might discriminate between subsets of alarminresponsive ILC2s. Additionally, IL-33 stimulation results in Nmur1 downregulation, thereby limiting NMU action on ILC2s following alarmin release. These data highlight a conserved mechanism of crosstalk between neurons (A) The intestine is innervated by both sympathetic (blue) and parasympathetic (red) nerves and is thereby connected to the central nervous system, but also encompasses an independent neurological network, the enteric nervous system (black). Nerve cells of the enteric nervous system, which extend into the villi, are organized in interconnected enteric ganglia forming submucosal and myenteric plexuses between the intestinal muscle layers [15, 16] . In very close proximity to enteric neurons are ILC2 cells (brown), which are innate immune cells capable of releasing type 2 cytokines in response to immune challenges and poised to be instructed by both neurological and epithelial mediators. Similarly, but not shown in the figure, ILC2s have been shown to be located close to neurons of the pulmonary innervation. (B) In the mucosa, ILC2s, epithelial cells and neurons form a neuro-immunological triangle. ILC2s resemble central effector cells instructed by both epithelial cytokines, e.g. IL-25, and the neuron-derived peptide NMU to release type 2 cytokines in response to an immune challenge, such as helminth infection, resulting in epithelial conditioning, goblet and tuft cell hyperplasia and amplification of local type 2 immunity. New evidence suggests that NMU release might be regulated directly by helminth-derived products, as well as by epithelial cytokines and, possibly, type 2 cytokines from ILC2s.
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A fascinating insight from these new studies is the intimate anatomical connection between the neuronal and innate lymphoid cells ( Figure 1A) . The finding that the innervation of the intestinal lamina propria and lung parenchyma is in closer proximity to resident ILC2s rather than T cells leads to several interesting, but as yet unanswered, questions regarding the function of this co-localization. Does NMU enjoy a very limited range of spatial activity within tissues, and are ILC2s instructed by nerve-derived NMU to migrate from the fixed sites of enteric innervation, and/or do they do so in response to the epithelial alarmins? In fact, in an ex vivo assay of ILC2 stimulation, NMU proved considerably more potent in promoting the production of ILC2 cytokines than the production of either IL-25 or IL-33 [8] or even a combination of both [7] . However, the physiological NMU concentration inside the lamina propria or lung tissue has yet to be established, and the degree of redundancy among the various ILC2 stimuli in vivo could be considerable. Certainly, bone marrow chimera experiments revealed reduced but not abrogated type 2 cytokine expression in lung Nmur1-deficient ILC2s compared with wild-type ILC2s following N. brasiliensis infection, demonstrating that no single ligand fulfills a unique and indispensable role [8] .
The significance of ILC2 function was initially established within the setting of helminth infection, so it is not surprising that these parasites elicit increased NMU production in murine gut tissue [7] . Cardoso et al. [8] and Klose et al. [7] focused their in vivo characterization on ILC2-neuron crosstalk ( Figure 1B) during infection with N. brasiliensis, which migrates through both the lung and the small intestine and induces strong type 2 immunity within these tissues. Nmur1-deficient mice showed increased worm burdens at early time points (days 2-7) in both tissues, along with compromised type 2 cytokine levels, airway eosinophilia and mast cell recruitment [7, 8] . However, N. brasiliensis was still expelled effectively by day 9 post-infection [8] , emphasizing again that the immune system can compensate, albeit tardily, through redundant mechanisms. As both lung and gut immunity is attenuated in Nmur1-deficient mice, delayed expulsion could reflect immune defects in either or both tissues. To circumvent this issue, Klose et al. [7] intraperitoneally injected NMU into wild-type mice at days 2, 4 and 6 post-infection, leading to a mildly, but significantly, reduced worm count at day 7, suggesting that intestinal NMU may indeed affect nematode survival. As NMU can also provoke intestinal smooth muscle contraction [9] , which is instrumental in helminth expulsion [10] , it was also important to pinpoint the role of hematopoietic cells. Thus, both groups injected bone marrow from wild-type or Nmur1-deficient mice into alymphoid mice (i.e. lacking Rag2 and Il2rg). Worm burdens were augmented in Nmur1-deficient bone marrow chimeras compared with mice reconstituted with wild-type cells [7, 8] , emphasizing the importance of NMU-activated ILC2s in anti-helminth immunity.
To test the effect of neuronal NMU release into the respiratory system outwith infection, two approaches were taken: direct intranasal administration of NMU [7] and intranasal instillation of the highly allergenic house dust mite (HDM) extract [6] . In the lung, NMU strongly induced ILC2 cytokine production and eosinophil recruitment, including in ILC2-reconstituted alymphoid mice [7] . In an elegant single-cell RNA sequencing approach, Wallrapp et al. [6] addressed the heterogeneity of ILC2 cells under resting conditions, after stimulation with epithelial cytokines, or following treatment with HDM. Strikingly, IL-25 and IL-33 induced different transcriptional profiles in ILC2s, with high Nmur1 expression at steady state and after IL-25 treatment, but reduced Nmur1 expression in the presence of IL-33. In particular, NMU amplified the pro-inflammatory capacity of IL-25, not only in vitro, but also in vivo when pulmonary pathophysiology was evaluated. In the HDM-driven allergic setting, however, Nmur1 deficiency resulted only in minor differences in immunological readouts, other than the phenotype of ILC2s themselves. Despite a reduction in ILC2 numbers and cytokine levels in Nmu-deficient mice after HDM challenge, this had no effect on the increased level of total inflammation and eosinophilic infiltration in these mice, which might be due to compensatory CD4+ T-cell recruitment to the site of inflammation. Similarly, when exposed to HDM, Nmur1-deficient mice showed only a mildly (though significantly) improved inflammatory score compared with wildtype mice [6] .
By opening a new window into the generation of type 2 immunity, the authors also provoke many further questions. For example, the nature of the molecular patterns from helminths or allergens that selectively trigger the type 2 pathway remain unresolved [11, 12] . Interestingly, the secretions of N. brasiliensis (previously reported to drive type 2 responses in vivo [13] ) elicit NMU production from neurons, indicating a pathogen recognition system in these cells. Direct neuronal sensing of microbial products has also been reported, most recently in an intestinal organ culture model [14] . Certainly, the adaptor protein MyD88 (which also transduces the IL-33 signal) is required within neuronal cells for optimal immunity, implying that there may be a positive feedback loop in which NMU production is amplified by IL-33 or other epithelial/ ILC2-derived signals [8] (Figure 1B) . Equally, although mice lacking mast cells or eosinophils show intact NMU-driven ILC2 activation [7] , it is known that these and other innate immune cell populations do participate in a fully orchestrated type 2 response to attack (appropriately) helminths and (inappropriately) allergens, and their interaction with neuronal cells seems highly likely.
These exciting papers open up a new dimension in the immunological network and add to the growing appreciation of the potentially pivotal role of the nervous system in driving the immune response [15, 16] . NMU is one of many smallmolecule mediators that act on immune cells, including vasoactive intestinal peptide, which regulates the interaction between ILCs and eosinophils in a circadian-clock-dependent manner [17] , and acetylcholine (ACh), which is released by the NMU-producing neurons in the intestine [7] . Interestingly, ACh signaling is known to be required for immunity to N. brasiliensis [18] . Returning the compliment, many immune cells produce neuroactive molecules, including ACh [19] , histamine, serotonin and catecholamines [20] , which in the latter case enable alternatively activated macrophages to regulate thermogenesis. While the full circuitry has yet to be mapped, it is clear that studies of the integration of neuronal and immune signaling will reveal many more critical interactions that will aid our understanding of neuroimmunology and our ability to regulate immune dysfunction through neurological pathways.
